Assenagon Asset Management S.A. purchased a new position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 15,128 shares of the company’s stock, valued at approximately $1,452,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Nordea Investment Management AB raised its position in shares of HealthEquity by 4.8% during the 4th quarter. Nordea Investment Management AB now owns 59,812 shares of the company’s stock worth $5,747,000 after buying an additional 2,757 shares in the last quarter. Everence Capital Management Inc. bought a new stake in HealthEquity during the fourth quarter worth approximately $233,000. GAMMA Investing LLC lifted its position in HealthEquity by 32.9% in the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock worth $120,000 after purchasing an additional 309 shares during the period. Franklin Resources Inc. boosted its stake in HealthEquity by 0.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock valued at $139,369,000 after purchasing an additional 11,659 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in HealthEquity during the 3rd quarter valued at $150,000. Institutional investors and hedge funds own 99.55% of the company’s stock.
HealthEquity Price Performance
Shares of NASDAQ:HQY opened at $104.71 on Friday. The company has a market cap of $9.07 billion, a price-to-earnings ratio of 96.06, a PEG ratio of 1.84 and a beta of 0.54. The business has a 50 day moving average price of $99.44 and a 200 day moving average price of $87.18. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $106.35.
Insiders Place Their Bets
In other news, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the sale, the director now owns 3,784 shares in the company, valued at $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,289 shares of company stock valued at $3,355,718. 2.20% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
HQY has been the subject of a number of recent analyst reports. BTIG Research increased their price target on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. JMP Securities upped their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Mizuho started coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. Finally, Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.
Read Our Latest Stock Analysis on HealthEquity
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
- Five stocks we like better than HealthEquity
- How to Short a Stock in 5 Easy Steps
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.